|
|
Volumn 531, Issue , 2016, Pages 560-
|
|
Transgender youth study kicks off
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GONADORELIN AGONIST;
SEX HORMONE;
GONADORELIN;
ADOLESCENCE;
ADOLESCENT;
BONE DENSITY;
BRAIN DEVELOPMENT;
DECISION MAKING;
EMPIRICAL RESEARCH;
HORMONAL THERAPY;
HUMAN;
JUVENILE;
NOTE;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PUBERTY;
SEX REASSIGNMENT;
TRANSGENDER;
TRANSGENDERISM;
ADOLESCENT BEHAVIOR;
AGONISTS;
CHILD;
CLINICAL TRIAL (TOPIC);
DRUG EFFECTS;
ECONOMICS;
NATIONAL HEALTH ORGANIZATION;
PHYSIOLOGY;
PSYCHOLOGY;
TIME FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
ADOLESCENT;
ADOLESCENT BEHAVIOR;
CHILD;
CLINICAL TRIALS AS TOPIC;
DECISION MAKING;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PUBERTY;
TIME FACTORS;
TRANSGENDER PERSONS;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 84962476978
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/531560a Document Type: Note |
|
Times cited : (17)
|
|
References (0)
|